Eagle Asset Management Inc Regeneron Pharmaceuticals, Inc. Transaction History

Eagle Asset Management Inc

  • $16.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 12, 2021
SELL
$478.3 - $607.98 $2.11 Million - $2.68 Million
-4,411 Closed
0 $0
Q3 2020

Nov 12, 2020
SELL
$544.75 - $658.21 $180,312 - $217,867
-331 Reduced 6.98%
4,411 $2.53 Million
Q2 2020

Aug 12, 2020
BUY
$493.32 - $643.92 $964,933 - $1.26 Million
1,956 Added 70.21%
4,742 $2.9 Million
Q1 2020

May 11, 2020
BUY
$336.18 - $494.43 $936,597 - $1.38 Million
2,786 New
2,786 $1.36 Million

Others Institutions Holding REGN

# of Institutions
1,529
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $81.1B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Eagle Asset Management Inc Portfolio

Follow Eagle Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email